Adolescents and young adults with cancer, as well as cancer survivors, are a group that have frequent contact with the health care system. They generally have a close relationship with oncology staff who they respect as credible medical experts.23 This context allows for more opportunities for health risk screening and preventive care than in healthy youth, which is appropriate given concerns of both the prevalence of risk behaviours and their attributable risk. In AYA cancer, it is unknown to what extent routine consultations have been utilised for wider screening. The wider chronic illness evidence suggests that health care providers infrequently discuss health risk behaviours or provide preventive counselling to young people with chronic illness.24,25,26 Just like adults, young people greatly value confidential health.27 Those with chronic disease have voiced greater desire to discuss broader health concerns with their health care provider, including issues such as education and mental health.28,29 This is a particular challenge for paediatric settings where young people with chronic illness are often seen with their parent(s). Without explicit efforts to see young people alone for at least part of each consultation, this too commonly translates to few opportunities to discuss confidential or sensitive concerns.30
Consent and adherence to treatment regimens
Specific aspects of adolescent development, such as progression from concrete to abstract thought patterns, a desire for autonomy and separation from parents and increased identification with the peer group, can clash with the demands of cancer treatment and adherence to treatment regimens. The most extreme example of this is outright refusal of treatment. Although most countries including Australia have a medico-legal framework that provides a context for decision-making about consent to treatment for legal minors, this issue remains complex and challenging for the young person, his or her parents and the health care providers involved. It could be argued that the more common developmental challenge for clinicians - of encouraging young people’s emerging capacity for self-management while helping parents to take on a more supportive ‘backseat’ role - is a different manifestation of the same developmental and medico-legal set of issues.31
More practically, psychosocial assessment is highly useful as a tool to understand the context in which adherence to any treatment regimen exists (or doesn’t). A particular focus should be about identifying ‘adherence hooks’, that is, reasons why the patient may benefit from particular health outcomes as seen from the young person’s point of view. A focus on problem solving that addresses how the young person might develop treatment routines in the context of their day to day activities can be especially helpful.31 Active participation of the young person in negotiating treatment plans is an important aspect of ensuring that they develop a sense of ownership and control over the disorder and its management.
Transition to adult health care
Finally, the effective transition of health care from the paediatric setting, with its strong focus on family centred care, to the more patient centred aspect of adult health care is also important to consider. This can occur in two ways. One approach is at the time of stable health for adolescent cancer survivors. Their health care can be transferred to adult services in a planned and coordinated manner in order to facilitate developmentally appropriate, risk-based guidelines for surveillance of late effects, as well as providing a different context for ongoing psychosocial assessment.32 Close attention needs to be paid at this time to ensure that young people who have completed active treatment do not inadvertently use the opportunity of transfer from paediatric to adult services to drop out of care.33 This highlights the importance of an active transition program. A second approach is a “crisis-oriented transition” that is more likely to occur at the time of a recently diagnosed primary or secondary or recurrent malignancy. In addition to age, type of malignancy and the upper age limit for admission to paediatric programs, psychosocial assessment can also help to identify developmental factors (such as maturity, autonomy, key supports) that may be important in considering whether treatment may be more appropriate in an adult or a paediatric setting.
While there are multiple models of transition, no single model is ideal. Rather, ensuring that each institution has a transition policy and ideally a transition program with close collaboration between paediatric and adult providers and active engagement of young people and their families, is integral to the success of transfer to adult health care.34,35
Conclusion
Adolescent and young adult cancer patients present challenges to health care professionals because of the impacts of cancer and its treatment on adolescent developmental tasks and reciprocally, the impact of adolescence on the disease itself. Improving health outcomes for adolescents and young adults with cancer is best achieved when the treatment is managed within a developmental understanding of the life of the young person and their family. The identification of preventable behaviours and mental health concerns through psychosocial screening is a necessary step towards preventive counselling and anticipatory guidance, with the aim of reducing morbidity and mortality from late effects, and improving psychosocial outcomes.
References
1. Ries L, Eisner M, Kosary C, Hankey BF, Miller BA, Clegg L, et al. SEER cancer statistics review, 1975-2002. Bethesda, MD: National Cancer Institute; 2005.
2. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic Health Conditions in Adult Survivors of Childhood Cancer. N Engl J Med. 2006;355(15):1572-1582.
3. Suris J-C, Michaud P-A, Viner R. The adolescent with a chronic condition. Part I: developmental issues. Arch Dis Child. 2004;89(10):938-942.
4. Pendley JS, Dahlquist LM, Dreyer Z. Body Image and Psychosocial Adjustment in Adolescent Cancer Survivors. J Pediatr Psychol. 1997;22(1):29-43.
5. Zebrack BJ, Zeltzer LK, Whitton J, Mertens AC, Odom L, Berkow R, et al. Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin's disease and non-Hodgkin's lymphoma: A report from the childhood cancer survivor study. Pediatrics. 2002;110(1):45-52.
6. Schultz KAP, Ness KK, Whitton J, Recklitis C, Zebrack B, Robison LL, et al. Behavioral and Social Outcomes in Adolescent Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2007;25(24):3649-3656.
7. Zebrack BJ, Gurney JG, Oeffinger K, Whitton J, Packer RJ, Mertens A, et al. Psychological Outcomes in Long-Term Survivors of Childhood Brain Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2004;22(6):999-1006.
8. Moore BD, III. Neurocognitive Outcomes in Survivors of Childhood Cancer. J Pediatr Psychol. 2005;30(1):51-63.
9. Jessor R. Risk Behavior in Adolescence: A Psychosocial Framework for Understanding and Action. J Adolesc Health. 1991;12(8):597-605.
10. Patton GC, Coffey C, Carlin JB, Sawyer SM, Wakefield M. Teen smokers reach their mid twenties. J Adolesc Health. 2006;29(2):214-20.
11. McCarty CA, Ebel BE, Garrison MM, DiGiuseppe DL, Christakis DA, Rivara FP. Continuity of Binge and Harmful Drinking From Late Adolescence to Early Adulthood. Pediatrics. 2004;114(3):714-719.
12. Suris J-C, Parera N. Sex, drugs and chronic illness: health behaviours among chronically ill youth. Eur J Public Health. 2005;15(5):484-488.
13. Suris JC, Akre C, Jeannin A, Berchtold A, Michaud P-A. Co-occurrence of risky behaviors among adolescents with chronic conditions. J Adolesc Health. 2007;40(2, Supplement 1):S5.
14. Suris J-C, Michaud P-A, Akre C, Sawyer SM. Health Risk Behaviors in Adolescents With Chronic Conditions. Pediatrics. 2008;122(5):e1113-1118.
15. Oeffinger KC, Robison LL. Childhood Cancer Survivors, Late Effects, and a New Model for Understanding Survivorship. JAMA. 2007;297(24):2762-2764.
16. Hollen PJ, Hobbie W. Decision making and risk behaviors of cancer-surviving adolescents and their peers. J Pediatr Oncol Nurs. 1993;13(3):121-134.
17. Verrill JR, Schafer J, Vannatta K, Noll RB. Aggression, Antisocial Behavior, and Substance Abuse in Survivors of Pediatric Cancer: Possible Protective Effects of Cancer and Its Treatment. J Pediatr Psychol. 2000;25(7):493-502.
18. Hollen PJ, Hobbie WL, Donnangelo SF, Shannon S, Erickson J. Substance Use Risk Behaviors and Decision-Making Skills Among Cancer-Surviving Adolescents. J Pediatr Oncol Nurs. 2007;24(5):264-273.
19. Bauld C, Toumbourou JW, Anderson V, Coffey C, Olsson C. Health-risk behaviours among adolescent cancer survivors. Pediatric Blood and Cancer. 2005;45(5):706-715.
20. Sawyer SM, Drew S, Yeo MS, Britto MT. Adolescents with chronic conditions: challenges living it and treating it. Lancet. 2007;367(9571):1481-1489.
21. Ozer EM, Adams S, Lustig J, Millstein S, Wibbelsman CJ, Elster A, et al. Do clinical preventive services make a difference in adolescent behavior. J Adolesc Health. 2002;32(2):132.
22. Goldenring JM, Rosen DS. Getting into adolescent heads: an essential update. Contemp Pediatr. 2004;21:64.
23. Hudson MM, Findlay S. Health-risk behaviors and health promotion in adolescent and young adult cancer survivors. Cancer. 2006;107(S7):1695-1701.
24. Zack J, Jacobs CP, Keenan PM, Harney K, Woods ER, Colin AA, et al. Perspectives of patients with cystic fibrosis on preventive counselling and transition to adult care. Pediatr Pulmonol. 2003;36(5):376-383.
25. Sawyer SM, Roberts KV. Sexual and reproductive health in young people with spina bifida. Dev Med Child Neurol. 1999;41(10):671-675.
26. Britto MT, Garrett JM, Dugliss MA, Johnson CA, Majure JM, Leigh MW. Preventive Services Received by Adolescents With Cystic Fibrosis and Sickle Cell Disease. Arch Pediatr Adolesc Med. 1999;153(1):27-32.
27. Ford CA, Millstein SG, Halpern-Felsher BL, Irwin Jr CE. Influence of physician confidentiality assurances on adolescents ' willingness to disclose information and seek future health care: A randomized controlled trial. JAMA. 1997;278(12):1029-1034.
28. Klein JD, Wilson KM. Delivering Quality Care: Adolescents' Discussion of Health Risks With Their Providers. J Adolesc Health. 2002;30(3):190-195.
29. Farrant B, Watson PD. Health care delivery: Perspectives of young people with chronic illness and their parents. J Paediatr Child Health. 2004;40(4):175-179.
30. Nash AA, Britto MT, Lovell D, Passo MH, Rosenthal SL. Substance use among adolescents with juvenile rheumatoid arthritis. Arthritis Care Res. 1998;11(5):391-396.
31. Sawyer S, Drew S, Duncan r. Adolescents with chronic disease: The double whammy. Aust Fam Physician. 2007;36(8):622-627.
32. Freyer DRR, Kibrick-Lazear R. In sickness and in health : Transition of cancer-related care for older adolescents and young adults. Cancer. 2006;107(S7):1702-1709.
33. Michelagnoli M, Viner R. Commentary. Eur J Cancer. 2001;37(12):1527-1530.
34. Sawyer S, Blair S, Bowes G. Chronic illness in adolescents: Transfer or transition to adult services. J Paediatr Child Health. 1997;33(2):88-90.
35. Rosen DS, Blum RW, Britto MT, Sawyer SM, Siegel DM. Transition to Adult Health Care for Adolescents and Young Adult With Chronic Conditions: Position Paper of the Society for Adolescent Medicine. J Adolesc Health. 2003;33(10):309-311.